Brief: Radiopharm Theranostics Says Australia's Nuclear Science And Technology Organisation Deal
Nov 22 (Reuters) - Radiopharm Theranostics RAD.AX :
* AGREEMENT WITH AUSTRALIA'S NUCLEAR SCIENCE AND TECHNOLOGY
ORGANISATION
* DEAL TO SUPPLY COMPANY WITH ISOTOPE NON-CARRIER-ADDED
LUTETIUM-177 (LU-177) FOR ITS TRIALS IN AUSTRALIA
Source text for Eikon: ID:nASXbVFmCX
Further company coverage: RAD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsNASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Radiopharm Theranostics To Meet With U.S. FDA To Align On Pivotal Phase 3 Trial Design For Rad 101 In Diagnosis Of Brain Metastases
NASDAQ RESUMED AT 09:56 AM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:50 AM